Furthermore, our findings strongly support the premise that AVMs in patients with hereditary hemorrhagic telangiectasia are likely to develop in areas of high local VEGF expression, known to occur in infection, wounding, and in hypoxic conditions. The gene discussed is VEGFA; the disease is infection.